Amgen (AMGN) PT Lowered to $298 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $472.08 +2.35%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Join SI Premium – FREE
Truist Securities analyst Robyn Karnauskas lowered the price target on Amgen (NASDAQ: AMGN) to $298.00 (from $333.00) while maintaining a Hold rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $400 at Bernstein SocGen Group
- AMD (AMD) PT Raised to $600 at DA Davidson
- SGHC Limited (SGHC) PT Lowered to $16 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
